Last Name

Ira Blaufarb

InstitutionMount Sinai
Address177 E87th Street
Suite 507
New York NY 10128

     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hamroff G, Katz SD, Mancini D, Blaufarb I, Bijou R, Patel R, Jondeau G, Olivari MT, Thomas S, Le Jemtel TH. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999 Mar 2; 99(8):990-2.
      View in: PubMed
    2. Hamroff G, Blaufarb I, Mancini D, Katz SD, Bijou R, Jondeau G, Olivari MT, Thomas S, LeJemtel TH. Angiotensin II-receptor blockade further reduces afterload safely in patients maximally treated with angiotensin-converting enzyme inhibitors for heart failure. J Cardiovasc Pharmacol. 1997 Oct; 30(4):533-6.
      View in: PubMed
    3. Blaufarb IS, Sonnenblick EH. The renin-angiotensin system in left ventricular remodeling. Am J Cardiol. 1996 May 30; 77(13):8C-16C.
      View in: PubMed
    4. Blaufarb I, Pfeifer TM, Frishman WH. beta-blockers. Drug interactions of clinical significance. Drug Saf. 1995 Dec; 13(6):359-70.
      View in: PubMed
    Blaufarb's Networks
    Click the "See All" links for more information and interactive visualizations!
    Similar People
    Same Department
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067